The performance metrics speak volumes. The iShares Biotechnology ETF (NASDAQ: IBB) has climbed 29.51% year to date through December 29, while the State Street SPDR S&P Biotech ETF (NASDAQ: XBI) has ...

Every item on this page was chosen by a Town & Country editor. We may earn commission on some of the items you choose to buy. The beauty industry’s landscape is constantly evolving, shaped by the rise ...

It’s a bit difficult to pin down exactly what people in the biotechnology industry mean by “artificial intelligence” (AI). In general, they seem content with a working definition, one that describes ...

The biotechnology industry presents a high-stakes investment landscape, where outcomes for investors are often binary and the line between success and failure is remarkably thin. In the best-case ...

The biotechnology industry is split between two very different types of companies. On one side are the large, blue-chip leaders like Amgen Inc. (ticker: AMGN), Gilead Sciences Inc. (GILD), Vertex ...